February 19, 2018

In This Issue
AMA Advocacy Conference Highlights High Drug Costs, Regulatory Relief and Coverage Concerns
MMA Board to Address Several Critical Issues at Annual President's Retreat in March
Use EMR System Defaults to Reduce Opioid Prescribing
CMS Projects Health Care Spending to Increase Significantly in Next Decade
Purdue Pharma Announces Cessation of Marketing Oxycontin to Prescribers
Health Access Network Names New Chief Executive Officer
Notes from the American Medical Association
3 Ways to Maximize Employer Diabetes Prevention Tools for Your Patients
Legislative Call This Tuesday, February 20th
Legislative Report: "Conversion therapy" and More
Healthcare Suicide Prevention Protocol Development Training - half day workshop - March 2
28th Annual Winter Conference - Contemporary Topics in Orthopedics - March 16-18
QC2018: Building Communities of Practice through Innovation - Wednesday, April 4, 2018
MMA and Jackson Laboratory Seeking Volunteers to Assist with 2018 Maine Cancer Genomics Initiative Forum
New Free CME on Alzheimer's Risk, Detection, and Management
Peer Navigation Program from Facing Our Risk of Cancer Empowered (FORCE)
Online Learning Opportunities Offering CME Credits - from the Northern New England Practice Transformation Network
Associate Director/Director of Compliance, Privacy, Risk and Legal Affairs for Penobscot Community Health Care in Bangor, Maine
MD/DO - Lewiston, ME
Chief Executive Officer CEO at Greater Portland Health
Outpatient Internal Medicine Physician Bangor, Maine
Relocate to Beautiful Southwestern Maine - Medical Director/Family Practice Physician
Clinical Cardiology Opportunity
Outpatient Only - Internal Medicine with Loan Repayment & Sign-on Bonus
Opportunities at the VA for Volunteer Physicians

Search Back Issues


Follow Us:

AMA Advocacy Conference Highlights High Drug Costs, Regulatory Relief and Coverage Concerns

Several issues were discussed with one or more members of the Maine Congressional Delegation, including the following:
  • The need for Congress to take action to address the high cost of drugs, including both brand-name products and generics. Drs. Schlager and Pattavina were able to bring several real life examples of extreme increasesEdit in costs including several in the field of rheumatology. 
  • The state by state distribution of the $6 billion dollars included earlier this month for responses to the opioid crisis.
  • Regulatory relief and the need for standardization of the increasingly burdensome prior authorization requirements.
  • Concern with the recently released President's budget which would make major cuts to the Office of National Drug Control Policy and to the CDC Prevention Fund, which was also negatively impacted by the spending bill already passed.
On the Senate side, we discussed with both Senator Collins and King the need to pass the two federal bills pending which would stablilize the insurance marketplace exchanges for two years. Second District Congressman Bruce Poliquin asked the opinion of MMA on the state's 1115 waiver application which would require that MaineCare patients, excluding certain vulnerable categories, either obtain work or provide community service of twenty hours per week. MMA's position is that while persons able to work should do so, they should not lose healthcare coverage if they are not in compliance with the requirement.
We also noted the pending issue of MaineCare expansion in Maine as a result of the passage of the ballot question in November of 2017. Governor LePage has until April 5 to file documents with CMS beginning the process.



Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©